Skin cancer levels have shown a significant increase in Northern Ireland since the early 1990s and are more likely to affect men, older people and those living in more affluent areas, according to a study just published in the June issue of British Journal of Dermatology.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for doripenem, an investigational carbapenem antibiotic for the treatment of nosocomial pneumonia, a pneumonia that is acquired in a hospital or other healthcare setting.
Obese men who find themselves short of breath even after moderate physical activity are invited to participate in a study by UT Southwestern Medical Center and the Institute for Exercise and Environmental Medicine.
Refugees in Australia have relatively low rates of hospital use, but they may be experiencing barriers to accessing hospital-based health care, refugee health specialists said in the latest edition of the ‘Medical Journal of Australia’.
Nurses who work the night shift are more likely to have poor sleep habits, a practice that can increase the likelihood of committing serious errors that can put the safety of themselves as well as their patients at risk, according to a research abstract that will be presented Monday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
The study investigating the claim was published in the June issue of Australian and New Zealand Journal of Public Health.
Self-rated health is a strong predictor of functional decline and mortality for elderly people presenting to a hospital emergency department, according to a new study published in the latest issue of Emergency Medicine Australasia, the journal of the Australasian College for Emergency Medicine.
Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life ? the human genome ? to figure out what makes these people susceptible to the disabling inflammatory condition.
Nearly half of all patients are currently being treated within 18 weeks, a year and a half ahead of schedule, according to the first official figures produced by the Department of Health today.
Roger Pebody from Terrence Higgins Trust said: It?s essential that anyone taking Nelfinavir (Viracept) contacts their HIV doctor or hospital without delay, to identify an alternative treatment to continue with.